Catalyst/MAP Global Balanced C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Catalyst/MAP Global Balanced Fund Class C TRXCX
- NAV / 1-Day Return 13.16 / +1.15 %
- Total Assets 14.9M
-
Adj. Expense Ratio
1.980%
- Expense Ratio 1.970%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Global Moderate Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity —
- Status Open
- TTM Yield 1.57%
- Turnover 60%
USD | NAV as of Jun 12, 2026 | 1-Day Return as of Jun 12, 2026, 1:06 AM GMT+0
Morningstar’s Analysis TRXCX
Will TRXCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the TRXCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of TRXCX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 29.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
SPDR® Gold MiniShares | 5.02 | 732,251 | — |
Aircastle Limited 4.25% | 4.28 | 624,160 | Cash and Equivalents |
Belo Corp. 7.75% | 3.30 | 480,864 | Corporate |
First American Treasury Obligs X | 3.28 | 478,951 | Cash and Equivalents |
Takeda Pharmaceutical Co Ltd ADR | 2.92 | 425,960 | Healthcare |
Methanex Corporation 5.125% | 2.89 | 422,262 | Corporate |
ArcelorMittal S.A. 6.55% | 2.83 | 412,351 | Corporate |
Bunge Global SA | 2.81 | 409,202 | Consumer Defensive |
Sanofi SA ADR | 2.49 | 362,699 | Healthcare |
Nestle SA ADR | 2.46 | 359,238 | Consumer Defensive |
United States